Appili Therapeutics Inc.

Categories

COMPUTERS, IT & TECHNOLOGY - BiotechnologyCOMPUTERS, IT & TECHNOLOGY - Research/DevelopmentGROWTH CHAMPIONS

About Us

Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. As part of a global consortium, Appili is sponsoring late-stage clinical trials evaluating the antiviral Avigan/Reeqonus for the worldwide treatment and prevention of COVID-19. The Company is also advancing a diverse range of anti-infectives, including a broad-spectrum antifungal, a vaccine candidate to eliminate a serious biological weapon threat, and two novel antibiotic programs. Led by a proven management team, Appili is at the epicenter of the global fight against infection.

Images

Gallery Image 3%20Champions.jpg

Stay Connected

Subscribe to our weekly e-newsletter and receive important updates on Halifax Chamber events, Member benefits and advocacy news.

Contact Us

The Halifax Chamber recognizes that we are in Halifax, or Kjipuktuk, in Mi’kma’ki, the ancestral and traditional lands of the Mi’kmaq people. We acknowledge the Peace & Friendship Treaties signed in this Territory and recognize that we are all Treaty People.

© 2022 Halifax Chamber of Commerce.

Robotics in Healthcare